What is SAA?
Human Serum Amyloid A protein (SAA) is an acute phase protein. It is a heterogeneous protein belonging to the apolipoprotein family, with a molecular weight of approximately 12,000. During an acute phase response, stimulated by IL-1, IL-6, and TNF, SAA is synthesized in the liver by activated macrophages and fibroblasts. Its concentration can increase to 100-1000 times its initial level, but it has a short half-life of only about 50 minutes.
Research Indicates
CRP and SAA are primarily used in the differential diagnosis of infectious diseases in children. Studies have found that in children with viral infections, the change in serum SAA levels is more sensitive than that of CRP. This suggests SAA can serve as a sensitive and reliable marker for diagnosing viral infections in children.
Particularly, the combined detection of the serum SAA/CRP ratio is more helpful in the differential diagnosis of bacterial versus viral infections in children. This is significant for guiding the rational use of antibiotics and for curbing and delaying the emergence of drug-resistant bacteria.
SAA is also a protein synthesized by liver cells. However, it begins to rise within 4-6 hours after a bacterial infection, peaks at around 6 hours, and rapidly returns to normal levels within 24 hours after the pathogen is cleared. This means SAA has higher sensitivity than CRP in bacterial infections. Unlike CRP, SAA levels increase significantly during viral infections, potentially rising by more than 1000-fold.
At this point, some might wonder: Since SAA is so effective, why are the "three routine tests" still needed? Wouldn't it be redundant? Could SAA simply replace CRP, being more economical and effective? However, the combined detection of SAA and CRP is not merely a repeat examination for clinical judgment; it represents a case of 1+1 > 2. Combining SAA and CRP tests offers complementary advantages and provides clinical value beyond what a single indicator can offer. It enables rapid and accurate determination of the infection type, providing effective experimental evidence for early diagnosis and subsequent treatment.
Common Clinical Combination Patterns
Based on their statistical analysis, an article in the Shanghai Journal of Medical Laboratory Sciences (2003, 18: P.227-228) recommended the combined detection of SAA and CRP to compensate for the lack of significant differences in CRP levels during viral infections. It was concluded that combined detection benefits the early diagnosis of infectious diseases in children.
A research report in the Chinese Journal of Nosocomiology (2006, 16: 1343-1346) also determined that the sensitivity and specificity of CRP combined with SAA for monitoring hospital infections were higher than those of white blood cell counts. The combined detection of SAA and CRP is also a sensitive indicator for early diagnosis of infection, as well as for evaluating treatment efficacy and prognosis.
An article titled "Application of Serum Amyloid A and C-Reactive Protein Detection in the Diagnosis of Infectious Diseases in Children" published in Laboratory Medicine (May 2017, Vol. 32, Issue 5) stated that the combined detection of CRP and SAA can determine the type of infection more quickly and accurately, providing effective laboratory evidence for early diagnosis and subsequent treatment!
In summary, the widespread application and diagnostic value of SAA in clinical laboratories have been recognized and supported by international authoritative institutions. To ensure the reliability and comparability of SAA test results across countries, an international standard preparation for SAA immunoassays was established. After its suitability was evaluated by seven laboratories across six countries using various different immunological methods, it was officially established and authorized by the WHO as the First International Standard for SAA immunology, coded 92/680.
Clinical Applications of SAA
An auxiliary diagnostic indicator for bacterial and viral infections, and a new marker for monitoring treatment efficacy.
SAA shows higher sensitivity, rises earlier, and decreases faster upon recovery compared to CRP in both viral and bacterial infections.
Broader clinical application scope: SAA levels increase in various conditions, including infectious diseases, cardiovascular diseases, tumors, transplant rejection, and amyloidosis.
Combined detection with CRP allows for rapid differential diagnosis of infection types; provides a more comprehensive reflection of the severity and treatment efficacy of infectious diseases and inflammation; and guides targeted treatment for patients at different disease stages.
Combined use with hsCRP can more effectively predict the potential risk of cardiovascular events.
More suitable for diagnosing infectious diseases in children, serving as a sensitive marker for the early detection of viral infections.
[Disclaimer: We respect originality and our main purpose is to share information. The copyright belongs to the original authors. If there is any infringement of your rights, please inform us immediately, and we will delete the content within 24 hours.]